Effect of Diet Composition on Liver Fat and Glucose Metabolism
DietLFAT
1 other identifier
interventional
16
1 country
2
Brief Summary
This study is designed to determine if the amount of fat and saturated fat in the diet contributes to the development of a condition called fatty liver disease in the absence of changes in weight.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2009
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
June 26, 2009
CompletedFirst Posted
Study publicly available on registry
June 30, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2012
CompletedDecember 3, 2015
December 1, 2015
3.3 years
June 26, 2009
December 1, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
hepatic triglyceride content by MRS
4 weeks
Secondary Outcomes (3)
insulin sensitivity
4 weeks
systemic and subcutaneous adipose tissue inflammation
4 weeks
oxidative stress markers
4 weeks
Interventions
4 weeks 55% fat/25% saturated fat isocaloric diet
4 weeks 20% fat/8% saturated fat isocaloric diet
Eligibility Criteria
You may qualify if:
- Age 18-55 years old, men and women, otherwise in good general health, BMI \>27 kg/m2
You may not qualify if:
- Abnormal glucose tolerance, fasting glucose\>100 mg/dl or diabetes
- History of liver condition or alanine aminotransferase (ALT) above the upper limit of the normal range
- Use of medications that cause insulin resistance or fatty liver: niacin, glucocorticoids, estrogens, tamoxifen, amiodarone, accutane, sertraline, atypical antipsychotics, anti-HIV medications
- Chronic use of anti-inflammatory medications (aspirin, ibuprofen, naprosyn, steroids, etc)
- Average alcohol intake \>20 grams/day
- Tobacco use
- Creatinine \>1.5 mg/dl for men and \>1.4 mg/dl for women
- Hematocrit \<33%
- Pregnancy or lactation
- Significant weight loss within the past 6 months (\>5% body weight)
- Claustrophobia or any contraindications to being placed in the magnet for the MRS scan such as pacemakers, defibrillators, brain aneurysm clips, etc.
- Other serious medical conditions or inflammatory conditions such as cancer, inflammatory arthritis, etc.
- History of multiple food allergies or intolerances or severe food allergies
- History of coronary artery disease, history of or treatment of hyperlipidemia, LDL \>200 mg/dl, fasting triglycerides \>300 mg/dl
- Weight \>300 pounds
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Washingtonlead
- VA Puget Sound Health Care Systemcollaborator
Study Sites (2)
University of Washington
Seattle, Washington, 98108, United States
VA Puget Sound Health Care System
Seattle, Washington, 98108, United States
Related Publications (2)
Marina A, von Frankenberg AD, Suvag S, Callahan HS, Kratz M, Richards TL, Utzschneider KM. Effects of dietary fat and saturated fat content on liver fat and markers of oxidative stress in overweight/obese men and women under weight-stable conditions. Nutrients. 2014 Oct 28;6(11):4678-90. doi: 10.3390/nu6114678.
PMID: 25353663RESULTvon Frankenberg AD, Marina A, Song X, Callahan HS, Kratz M, Utzschneider KM. A high-fat, high-saturated fat diet decreases insulin sensitivity without changing intra-abdominal fat in weight-stable overweight and obese adults. Eur J Nutr. 2017 Feb;56(1):431-443. doi: 10.1007/s00394-015-1108-6. Epub 2015 Nov 28.
PMID: 26615402RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristina M Utzschneider, MD
VA Puget Sound Health Care System/University of Washington
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine
Study Record Dates
First Submitted
June 26, 2009
First Posted
June 30, 2009
Study Start
June 1, 2009
Primary Completion
September 1, 2012
Study Completion
September 1, 2012
Last Updated
December 3, 2015
Record last verified: 2015-12